Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Medical Cannabis to Grow 36% Through 2024.

Medical Cannabis to Grow 36% Through 2024.The global medical cannabis market is projected to grow 36% per year through 2024, according to a report by Global Market Insights. The growth will be driven by many population segments, including by older people suffering from chronic pain due to neurology diseases, cancer and arthritis.

According to Boston University School of Public Health, about 1 in 5, or 1.5 billion, people suffer from chronic pain globally.

Other findings in the report include:

  • The global medical cannabis market will surpass US$55 billion by 2024
  • The global medical inhalation market was valued at US$ 5.3 billion in 2017 driven by its more controlled dosage rates and faster absorption
  • The global topical medical cannabis market was valued at US $349 million in 2017
  • The U.S. medical cannabis dispensaries market segment was US $2.1 billion in 2017
  • 29 states plus Washington D.C. have approved medical cannabis sales and use. More are expected.
  • The epidemic of opioid addiction is a factor driving appeal of medical cannabis over traditional pain relievers.
  • Israel and Australia have approved medical cannabis for certain conditions, driving new growth
  • The Israeli market was valued at US$ 39 million in 2017, where new reform allows sales in pharmacies

Among the many cannabis producers expected to gain from the market growth are Canopy Growth, Aurora Cannabis, GW Pharmaceuticals, Aphria, CanniMed, Tilray, Emerald Health Therapeutics, MedReleaf, and others.

Source: Global insights press release

Medical Cannabis to Grow 36% Through 2024.

About Cannin Investment Group: Your Pot Stocks Experts

Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in pot stocks? No! This is the perfect time to invest.

Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.

Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?

Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • 108% Backtested since 2012

We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best pot stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Buy